Position in IONS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,843,957,869
-$60,386,040 QoQ
Shares Held
24,556,637
+2.0% QoQ
Ownership
14.9%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.99336228328008.ToString("F0")%
Shared 0.ToString("F0")%
None 0.006637716719923824.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,683,576,696 across 351 Biotechnology names. IONS ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
This page
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in IONS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,843,957,869 | 24,556,637 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,904,343,909 | 24,072,101 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,549,736,864 | 23,689,038 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $934,134,532 | 23,642,990 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $712,421,857 | 23,613,585 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $793,224,603 | 22,689,491 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $900,529,929 | 22,479,529 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,043,506,453 | 21,894,806 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $947,749,561 | 21,862,735 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,088,740,913 | 21,520,872 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $975,191,101 | 21,498,922 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $880,660,369 | 21,463,816 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $766,134,577 | 21,436,334 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $804,784,991 | 21,307,519 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $941,707,962 | 21,291,159 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $787,399,110 | 21,269,560 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $789,725,616 | 21,320,886 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $644,553,105 | 21,181,502 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $710,114,044 | 21,172,154 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $843,452,309 | 21,144,455 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $948,381,564 | 21,093,896 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,183,836,442 | 20,938,034 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $990,136,872 | 20,866,952 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,226,990,263 | 20,810,554 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $990,999,532 | 20,960,227 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||